Sign in Subscribe

stem cell

M&A

Best World takes up 12.5% stake in A*STAR biotech start-up for $5.6 mil

SINGAPORE (Jan 14): Best World has agreed to acquire a 15% stake in Celligenics, a biomedical A*STAR spin-off start-up, in two investment phases.  

January 14, 2019

×